News | January 06, 2014

GE Healthcare’s SensorySuite Customizes Mammography Patient Experience

rsna 2013 mammography systems women's healthcare ge sensory suite
January 6, 2014 — GE Healthcare showcased its SensorySuite “cocoon” experience at the Radiological Society of North America Annual Meeting (RSNA 2013). This 3-D, fully immersive video simulates SensorySuite by plunging participants into the overall SensorySuite patient experience. SensorySuite surrounds a woman with an interactive mammography experience designed to simultaneously stimulate three senses — sight, smell and hearing — helping to distract the patient from the discomfort, pain and anxiety of a mammogram.
 
“Sensory Suite exemplifies our vision by capturing the essence of a woman’s sense of serenity through a calming, surreal environment while facilitating the completion of her exam with the most state-of-the-art mammography unit,” said Kathy Schilling, M.D., medical director, and Shakira Sarquis-Kolber, director, Women’s Imaging Boca Raton, Fla. “It is the perfect combination of high-tech and high-touch.”
 
“During the mammogram, our patients are generally stressed and tense,” said Dr. André Crèvecoeur, CEO, Center of Senology, Liége, Belgium. “They fear in one hand that it will hurt and in the other hand the result. We acquired SensorySuite seven months ago, and we had very positive feedback from our patients.”
 
The November 2013 SensorySuite Marketing Research Study, performed with 250 patients in two different SensorySuite sites, showed that 64.4 percent of women felt relaxed during the mammogram examination, and 99.6 percent of all the patients were likely to return to the same facility for their next mammogram.
 
By giving women the control to choose from one of three environmental ambiances — seaside, garden or waterfall, SensorySuite aims to encourage better overall mammography, cooperation and compliance. SensorySuite is available for use with existing or new Senographe Essential, Senographe Care or Senographe DS systems.
 
For more information: www.gehealthcare.com, www.rsna.org

Related Content

Christopher Comstock, M.D., ECOG-ACRIN Cancer Research Group study published in JAMA builds evidence for use of abbreviated MRI in women with dense breasts

Christopher Comstock, M.D., (Memorial Sloan Kettering Cancer Center) is the lead author of a paper in JAMA that reports that abbreviated breast MRI detected significantly more (almost 2 and a half times as many) breast cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breasts. Photo courtesy of Memorial Sloan Kettering Cancer Center

News | Breast Imaging | February 26, 2020
February 26, 2020 — According to a study
Women 75-plus May Not Benefit from Breast Cancer Screening
News | Mammography | February 25, 2020
February 25, 2020 — According to newly published research in an article titled...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...